Ryan S. Keh
Stott Lane
Salford, ENG, United Kingdom
Salford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Front-line systemic treatment outcomes in POEMS syndrome.
Journal: British journal of haematology
Published: September 27, 2025
Volrustomig/Rilvegostomig related "triple M"-myasthenia gravis and overlap syndrome.
Journal: Postgraduate medical journal
Published: March 07, 2025
Immune checkpoint inhibitor-related myasthenia gravis, myocarditis and myositis: further insights.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: February 13, 2025
Plasma periaxin is a biomarker of peripheral nerve demyelination.
Journal: Brain : a journal of neurology
Published: November 14, 2024
Reply: Peripherin is a biomarker of axonal damage in Guillain-Barré syndrome: a pathophysiological annotation.
Journal: Brain : a journal of neurology
Published: August 02, 2023
Peripherin is a biomarker of axonal damage in peripheral nervous system disease.
Journal: Brain : a journal of neurology
Published: March 27, 2023
Daratumumab-bortezomib-dexamethasone use in relapsed POEMS syndrome.
Journal: EJHaem
Published: April 07, 2022
COVID-19 vaccination and Guillain-Barré syndrome: analyses using the National Immunoglobulin Database.
Journal: Brain : a journal of neurology
Published: December 07, 2021
IgG1 pan-neurofascin antibodies identify a severe yet treatable neuropathy with a high mortality.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: February 10, 2021
Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome.
Journal: Brain : a journal of neurology
Published: July 30, 2020
Last Updated: 09/26/2026